These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3103592)

  • 1. Characteristics of anticellular activities of human recombinant interferon gamma on gynecological malignancies: in vitro sensitivity.
    Iwasaka T; Yoshimura T; Sugimori H
    Asia Oceania J Obstet Gynaecol; 1986 Dec; 12(4):549-54. PubMed ID: 3103592
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic anticellular and antiviral activities of human recombinant interferon-gamma and -beta.
    Gomi K; Kimura H; Okabe M; Oka T; Morimoto M
    J Pharmacobiodyn; 1986 Nov; 9(11):871-8. PubMed ID: 3031263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of augmentation of cell-mediated cytotoxic activities by recombinant human interferon-gamma (Met-Gln form): a comparative study with natural human interferon-alpha and -beta.
    Matsumoto S; Imanishi H
    Chem Pharm Bull (Tokyo); 1986 Nov; 34(11):4767-74. PubMed ID: 3103937
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticellular activities of human fibroblast interferon beta and human recombinant interferon gamma. Cytologic changes in a cervical cancer cell line.
    Iwasaka T; Yoshimura T; Ohkuma Y; Tsugitomi H; Sugimori H
    Acta Cytol; 1987; 31(6):941-5. PubMed ID: 3122483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of antiviral and anticellular activities of human recombinant interferon-gamma.
    Gomi K; Morimoto M; Nakamizo N
    Jpn J Cancer Res; 1985 Mar; 76(3):224-34. PubMed ID: 3922841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of human gamma-interferon to human epidermal tumor cells with different susceptibilities.
    Nagao S; Sato K; Osada Y
    Cancer Res; 1986 Jul; 46(7):3279-82. PubMed ID: 3085920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon-gamma.
    Taverne J; Rayner DC; Van der Meide PH; Lydyard PM; Bidey SP; Cooke A
    Eur J Immunol; 1987 Dec; 17(12):1855-8. PubMed ID: 3121361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.
    Sugarman BJ; Aggarwal BB; Hass PE; Figari IS; Palladino MA; Shepard HM
    Science; 1985 Nov; 230(4728):943-5. PubMed ID: 3933111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological characteristics of interferon-r-induced resistant histiocytic lymphoma cell line U937.
    Ho CK; Wang SY; Ou BR
    Proc Natl Sci Counc Repub China B; 1987 Apr; 11(2):100-6. PubMed ID: 3112822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human interferon-gamma inhibits adenovirus multiplication in vitro.
    Mistchenko AS; Falcoff R
    J Gen Virol; 1987 Mar; 68 ( Pt 3)():941-4. PubMed ID: 3102686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative and antiproliferative effects of interferon-gamma and tumor necrosis factor-alpha on cell lines derived from cervical and ovarian malignancies.
    Mutch DG; Massad LS; Kao MS; Collins JL
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1920-4. PubMed ID: 2124085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different kinetics of antiviral and anticellular activities between human recombinant and natural interferon-gamma arising from different receptor-binding properties.
    Gomi K; Akinaga S; Inoue A; Morimoto M; Nakamizo N
    Jpn J Cancer Res; 1986 Sep; 77(9):946-55. PubMed ID: 3095289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an interferon-resistant mutant of the human breast cancer cell line BT-20.
    Marth C; Gastl G; Zech J; Zilla P; Mayer I; Fasol R; Huber C; Daxenbichler G
    J Interferon Res; 1987 Apr; 7(2):195-202. PubMed ID: 3112248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the in vitro biological activities of recombinant bovine tumor necrosis factor (rBoTNF) alpha. I. Synergistic antiviral efficacy of rBoTNF alpha, recombinant bovine interferon gamma (rBoIFN gamma) and their combination.
    Campos M; Ohmann HB; Hughes G; Babiuk LA; Lawman MJ
    Antiviral Res; 1988 Nov; 10(1-3):71-81. PubMed ID: 2852921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of human neonatal natural killer cytotoxicity to herpes simplex virus with use of recombinant human interferons: lack of neonatal response to gamma interferon.
    Oh SH; Gonik B; Greenberg SB; Kohl S
    J Infect Dis; 1986 Apr; 153(4):791-3. PubMed ID: 3005439
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant gamma-interferon stimulates iodide uptake and cyclic AMP production by the FTRL5 thyroid cell line.
    Weetman AP
    FEBS Lett; 1987 Aug; 221(1):91-4. PubMed ID: 3040468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced inhibition of anticancer drugs by human recombinant gamma-interferon for human renal cell carcinoma in vitro.
    Gohji K; Maeda S; Sugiyama T; Ishigami J; Kamidono S
    J Urol; 1987 Mar; 137(3):539-43. PubMed ID: 3102760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential induction of indoleamine-2,3-dioxygenase (IDO) by interferon-gamma in human gynecologic cancer cells.
    Leung BS; Stout LE; Shaskan EG; Thompson RM
    Cancer Lett; 1992 Sep; 66(1):77-81. PubMed ID: 1451099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant gamma interferon induces HLA-DR expression on squamous cell carcinoma, trichilemmoma, adenocarcinoma cell lines, and cultured human keratinocytes.
    Kameyama K; Tone T; Eto H; Takezaki S; Kanzaki T; Nishiyama S
    Arch Dermatol Res; 1987; 279(3):161-6. PubMed ID: 2439027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the antiviral and anticellular activities of interferons by mixtures of HuIFN-gamma and HuIFN-alpha or HuIFN-beta.
    Oleszak E; Stewart WE
    J Interferon Res; 1985; 5(2):361-71. PubMed ID: 2989390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.